An Industry Veteran’s Insight on Data Governance and Provenance

Insider’s Advice for Starting, Growing, Exiting a Biotech

How AI is Changing the Antibody R&D Game

Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix

The Critical Role of Starting Materials & Processes in Advanced Therapies

Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts

Essential Program Management Considerations for Biopharma With Jamie Martin

Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa

Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa

Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt

Identifying Impurities In Gene Therapy With Santoshkumar Khatwani

The Risks and Rewards of Speed-to-IND Strategies With Susan Jones

Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy

Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business

Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy

The Financial Impact of a Continuous Bioprocessing Strategy

Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy

Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing

Navigating Scale-Up Challenges in Protein Production

Anticipating Disruptions: Identifying and Planning for Shortages

Cell and Gene Therapy: Managing the ‘Build or Buy’ Decision

Operational Efficiencies: Lower Operational Costs by Reducing Clinical GMP Sampling

The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection